Johnson & Johnson (JNJ) Earnings Date, Estimates & Call Transcripts $155.27 +0.36 (+0.23%) As of 03:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Johnson & Johnson Latest Earnings SummaryUpcoming Q1 Earnings DateApr. 15Before Market OpensEstimatedActual EPS (Jan. 22) $2.04 Beat By $0.05 Consensus EPS (Jan. 22) $1.99 Johnson & Johnson issued Q4 2024 earnings on January 22, 2025, reporting an EPS of $2.04, which beat analysts' consensus estimates of $1.99 by $0.05. Quarterly revenue rose 5.3% year-over-year to $22.52 billion, above the consensus estimate of $22.44 billion. With a trailing EPS of $6.65 and a P/E Ratio of 23.30, Johnson & Johnson's earnings are expected to grow 4.63% next year, from $10.58 to $11.07 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by JNJ Upcoming EarningsJohnson & Johnson's next earnings date is estimated for Tuesday, April 15, 2025, based off prior year's reporting schedules. Get Johnson & Johnson Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Johnson & Johnson and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataJNJ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JNJ Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Johnson & Johnson Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252$2.55$2.60$2.58 Q2 20252$2.61$2.69$2.65 Q3 20252$2.78$3.13$2.96 Q4 20252$2.33$2.48$2.41 FY 20258$10.27$10.90$10.59 Q1 20261$2.66$2.66$2.66 Q2 20261$2.76$2.76$2.76 Q3 20261$2.79$2.79$2.79 Q4 20261$2.83$2.83$2.83 FY 20264$11.04$11.04 $11.04 Johnson & Johnson Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/15/2025(Estimated)-------1/22/2025Q4 2024$1.99$2.04+$0.05$1.41$22.44B$22.52B10/15/2024Q3 2024$2.21$2.42+$0.21$3.73$22.17B$22.47B7/17/2024Q2 2024$2.71$2.82+$0.11$3.71$22.33B$22.45B4/16/2024Q1 2024$2.64$2.71+$0.07$3.22$21.39B$21.38B1/23/2024Q4 2023$2.28$2.29+$0.01$2.91$21.02B$21.40B10/17/2023Q3 2023$2.52$2.66+$0.14-$4.89$21.00B$21.35B7/20/2023Q2 2023$2.62$2.80+$0.18$3.64$24.63B$25.53B4/18/2023Q1 2023$2.51$2.68+$0.17$5.39$23.61B$24.75B Johnson & Johnson Earnings - Frequently Asked Questions When is Johnson & Johnson's earnings date? Johnson & Johnson has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 15th, 2025 based off last year's report dates. Learn more on JNJ's earnings history. What guidance has Johnson & Johnson issued on next quarter's earnings? Johnson & Johnson updated its FY25 earnings guidance on Wednesday, January, 22nd. The company provided earnings per share guidance of $10.50-10.70 for the period, compared to the consensus estimate of $10.55. Did Johnson & Johnson beat their earnings estimates last quarter? In the previous quarter, Johnson & Johnson (NYSE:JNJ) reported $2.04 earnings per share (EPS) to beat the analysts' consensus estimate of $1.99 by $0.05. Learn more on analysts' earnings estimate vs. JNJ's actual earnings. How can I listen to Johnson & Johnson's earnings conference call? The conference call for Johnson & Johnson's latest earnings report can be listened to online. Listen to Conference Call How can I read Johnson & Johnson's conference call transcript? The conference call transcript for Johnson & Johnson's latest earnings report can be read online. Read Transcript How much revenue does Johnson & Johnson generate each year? Johnson & Johnson (NYSE:JNJ) has a recorded annual revenue of $88.82 billion. How much profit does Johnson & Johnson generate each year? Johnson & Johnson (NYSE:JNJ) has a recorded net income of $14.07 billion. JNJ has generated $6.65 earnings per share over the last four quarters. What is Johnson & Johnson's price-to-earnings ratio? Johnson & Johnson (NYSE:JNJ) has a trailing price-to-earnings ratio of 23.30 and a forward price-to-earnings ratio of 14.63. The price/earnings-to-growth ratio is 2.46. What is Johnson & Johnson's EPS forecast for next year? Johnson & Johnson's earnings are expected to grow from $10.58 per share to $11.07 per share in the next year, which is a 4.63% increase. More Earnings Resources from MarketBeat Related Companies Eli Lilly and Company Earnings AbbVie Earnings Merck & Co., Inc. Earnings Pfizer Earnings Bristol-Myers Squibb Earnings Zoetis Earnings Royalty Pharma Earnings Jazz Pharmaceuticals Earnings Corcept Therapeutics Earnings Perrigo Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? This page (NYSE:JNJ) was last updated on 2/18/2025 by MarketBeat.com Staff From Our PartnersTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | SponsoredNvidia Is About to Shock the World: March 17thIf you have money in any artificial intelligence stock or are interested in AI… Mark this date on your cale...Brownstone Research | SponsoredThe Elon Coup?According to an extremely well connected group of financial forecasters (with connections in the Pentagon and ...Altimetry | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredHow You Could Invest in Elon’s ‘Final Move’What if I told you Elon Musk's next big venture could leave Tesla and SpaceX in the dust? It may sound unbe...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
